Collaborations & Alliances
Related Searches:
Filter by:
361 - 375 of 1089 results
August 5, 2011
Italian company to provide cell-based therapy services
Read More »
August 3, 2011
Combinatorial tech assists in stem cell research
Read More »
August 2, 2011
Migraine med NDA filing triggers collaboration payment
Read More »
August 2, 2011
Alliance paves way for development of Web-Call centers in North America
Read More »
August 1, 2011
Parsons named to lead new commercialization unit
Read More »
July 25, 2011
Will conduct cGMP manufacturing of clinical batches through 2013, plus customer option for commercial supplies
Read More »
July 25, 2011
Process dev., scale-up pact covers melanoma treatment
Read More »
July 25, 2011
Will make sterile injectable of novel heart failure drug
Read More »
July 25, 2011
Agreement adds advanced lipid testing to CRO offering
Read More »
July 20, 2011
Collaboration covers Victrelis in combination therapy
Read More »
July 19, 2011
Move adds natural products library to drug discovery offerings
Read More »
July 14, 2011
Collaboration will aid in biologic, biosimilar development
Read More »
July 14, 2011
OSDrC delivery tech adds to Catalent's oral solid dosage offerings
Read More »
July 13, 2011
Aslan Pharmaceuticals and Array BioPharma have entered into a license agreement to develop Array’s HER2/EGFR inhibitor, ARRY-543, currently in Phase II development for solid tumors.
Read More »
July 13, 2011
Particle Sciences, Inc. (PSI) and Absorption Systems have formed a partnership to provide clients with enhanced drug development services by integrating preclinical pharmacokinetic data into the dosage form development.
Read More »
361 - 375 of 1089 results
